Improving human coronavirus OC43 (HCoV-OC43) research comparability in studies using HCoV-OC43 as a surrogate for SARS-CoV-2
Article
[키워드] accompany
acute respiratory syndrome
added
African green monkey
analyzed
antibodies
antibody concentration
approach
biosafety
BSL-3
Cell
cell line
cells
Colon cancer
Combination
common cold
comparability
complicate
conducted
coronavirus
counter
CPE
Culture
Cytopathic effect
days post infection
demonstrated
described
droplet
fibroblast
Flow virometry
growth
Growth Curve
HCoV-OC43
human coronavirus
human coronavirus OC43
human lung
Improving
Infection
infectious dose
investigated
kidney
less
multiplicity of infection
pandemic
parameter
Plaque assay
produced
quantification
quantified
reached
reducing
reproducibility
required
Research
respiratory aerosol
Respiratory system
Sample
SARS-CoV-2
Sartorius
Seven
Standardization
target
TCID
these cell
tissue
transmitted
Vero E6
Vero E6 cell
virion
virus particle
Virus titration
[DOI] 10.1016/j.jviromet.2021.114317 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.jviromet.2021.114317 PMC 바로가기 [Article Type] Article